| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1530482A1 Use of urease for inhibiting cancer cell growth |
| 05/18/2005 | EP1530481A1 Enzyme containing composition, process of producing said composition and its use |
| 05/18/2005 | EP1389128A4 Method for inhibiting atherosclerotic plaque formation |
| 05/18/2005 | EP1341909B1 A method for in vitro molecular evolution of protein function |
| 05/18/2005 | EP1330262B1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 05/18/2005 | EP1285928B1 Antibiotics tripropeptins and process for producing the same |
| 05/18/2005 | EP1261367B1 Use of interleukin-6 antagonists for the treatment of oestrogen dependent tumours |
| 05/18/2005 | EP1161530B1 Protein for blocking platelet adhesion |
| 05/18/2005 | EP1063975B1 Crosslinkable macromers bearing initiator groups |
| 05/18/2005 | EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 05/18/2005 | EP0970187B1 Pituitary differentiation factor and methods of use thereof |
| 05/18/2005 | EP0894141B1 Hybrid proteins which form heterodimers |
| 05/18/2005 | EP0839055B1 Modified methioninase, its use, recombinant host cells producing high levels of methioninase and method for purifying methioninase |
| 05/18/2005 | EP0830138B1 Use of fibroblast growth factor analogues to stimulate bone growth |
| 05/18/2005 | EP0662137B1 Gene transcription and ionizing radiation: methods and compositions |
| 05/18/2005 | CN1618018A Process for the measurement of the potency of glatiramer acetate |
| 05/18/2005 | CN1617890A Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 05/18/2005 | CN1617887A Corticotropin releasing factor receptor 2 agonists |
| 05/18/2005 | CN1617886A Corticotropin releasing factor receptor 2 agonists |
| 05/18/2005 | CN1617885A Corticotropin releasing factor receptor 2 agonists |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617883A Solid salts of benzazepine compounds and pharmaceutical compositions containing them |
| 05/18/2005 | CN1617740A Immunisation against chlamydia trachomatis |
| 05/18/2005 | CN1617739A Methods and compositions for treating lesions of the respiratory epithelium |
| 05/18/2005 | CN1617738A Catheter composition and uses thereof |
| 05/18/2005 | CN1617737A Compositions and method for normalizing lipid levels in mammalian tissues |
| 05/18/2005 | CN1617736A Vaccine and method for treatment of motor neurone diseases |
| 05/18/2005 | CN1617735A Storage-stable fibrin sealant |
| 05/18/2005 | CN1617734A Method and device for concentrating and stabilising conjugated oestrogens from the urine of mares |
| 05/18/2005 | CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 05/18/2005 | CN1617719A Combination comprising a P-GP inhibitor and an anti-epileptic drug |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1617704A Composition comprising at least one oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 05/18/2005 | CN1617703A Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof |
| 05/18/2005 | CN1617670A Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 05/18/2005 | CN1616661A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 05/18/2005 | CN1616652A Gene engineering bacteria of high efficiency expression of human alpha 1-thymulin and its construction method and use |
| 05/18/2005 | CN1616491A Fusion protein with cold proventing and curing function and its encoding gene and use |
| 05/18/2005 | CN1616487A Liver cancer apoptosis inducing factor and its encoding gene and use |
| 05/18/2005 | CN1616485A SARS coronavirus structure protein ORF3 and its use |
| 05/18/2005 | CN1616484A Novel cyclopeptide anti-tumor, anti-virus antibiotic active compound |
| 05/18/2005 | CN1616483A A group of artificially synthetic antibacterial peptide and its preparing method and use |
| 05/18/2005 | CN1616432A Compound, its use and pharmaceutical compositions comprising same |
| 05/18/2005 | CN1616092A Compound lysoamidase spray agent and preparing method |
| 05/18/2005 | CN1616091A Compound protease medicine for treating prostate proliferation and its preparing method |
| 05/18/2005 | CN1616090A Medicine for treating radioactive membrana mucosa damage, repeative aphtha and paradentitis |
| 05/18/2005 | CN1616089A Sodium ferulic acid albumin nano granular preparation and its preparing method |
| 05/18/2005 | CN1616088A Interferon oculentum |
| 05/18/2005 | CN1616087A Nerve growth factor (NGF) liposome |
| 05/18/2005 | CN1616086A Nerve growth factor external application medicine and its preparing method |
| 05/18/2005 | CN1616085A A composition for the prevention and/or treatment of atherosclerosis |
| 05/18/2005 | CN1616084A Botulinum toxin pharmaceutical compositions |
| 05/18/2005 | CN1616083A Daptomycin freeze-dried preparation for injection and preparing method |
| 05/18/2005 | CN1616082A Use of compound methionine enkephalin as medicine for treating brain cancer, kidney cancer and liver cancer |
| 05/18/2005 | CN1616081A Use of chemical synthetic antifungal disome peptide for treating pathogenic fungus infection |
| 05/18/2005 | CN1616080A Faluopeinan medicine composition containing glutathione |
| 05/18/2005 | CN1202252C Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 05/18/2005 | CN1202248C Flat-chin sea snake long-chain neurotoxin gene and its expression and application |
| 05/18/2005 | CN1202247C Chimeric heteromultimer adhesins |
| 05/18/2005 | CN1202129C GDNF mutant and its medical application |
| 05/18/2005 | CN1202128C Immunogenicity of modified protein |
| 05/18/2005 | CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment |
| 05/18/2005 | CN1202124C Artificial synthetic organic polypeptide compound and its use |
| 05/18/2005 | CN1202123C Crystalline forms of IS-[la(pha(2S, 3R),9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl) carbonyl]-amino] actahydro-6H-piridazino [1,2-A] [1,2] diazepin-1-carboxamide |
| 05/18/2005 | CN1201820C Compositions containing benzimidazolones and progestogens |
| 05/18/2005 | CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/18/2005 | CN1201817C Tumor CT antigen immune inducing agent for treating liver cancer and its prepn |
| 05/18/2005 | CN1201816C Pharmaceutical formulations for IGF/IGFBP |
| 05/18/2005 | CN1201815C Stabilizer for recombinant alpha-interferon liquid |
| 05/18/2005 | CN1201814C Treatment of cardiao megaly |
| 05/18/2005 | CN1201813C Medicine composition, preparing method thereof and its use preparing medicines for curing SARS and SARS-induced cardio-cerebro complication |
| 05/18/2005 | CN1201812C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 05/18/2005 | CN1201728C Incorporation of active substances in carrier matrixes |
| 05/17/2005 | US6894171 Protease inhibitors; viricides; purity, crystal structure |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894154 Medical equipment comprising nucleic acid codes for wild-type human kinase interacting stathmin (hKIS) phosphoproteins, used for drug delivery; antiproliferative agents |
| 05/17/2005 | US6894153 Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells |
| 05/17/2005 | US6894150 Blood substitute for human/mammal transfusions in vivo; comprises lysis/centrifugation of erythrocytes; cross-linking |
| 05/17/2005 | US6894147 Intermediate conductance calcium-activated potassium channels (IK1) |
| 05/17/2005 | US6894146 Anticarcinogenic drugs for prevention of disease; fusion proteins; genetic engineering |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894058 Administering statin drug |
| 05/17/2005 | US6894033 Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 05/17/2005 | US6894031 Polynucleotides; in situ injection |
| 05/17/2005 | US6894029 Use of jellyfish collagen (type II) in the treatment of rheumatoid arthritis |
| 05/17/2005 | US6894028 Use of KPV tripeptide for dermatological disorders |
| 05/17/2005 | US6894027 Stimulation of bone growth with thrombin peptide derivatives |
| 05/17/2005 | US6894024 Administering a therapeutically effective amount of a GLP-1 (glucagon like peptide-1) molecule for therapy of hibernating myocardium |
| 05/17/2005 | US6894023 Salt formation, heating, isolation |
| 05/17/2005 | US6893870 Pancreas-derived plasminogen activator inhibitor |
| 05/17/2005 | US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 05/17/2005 | US6893858 Human kcnq5 potassium channel, methods and compositions thereof |
| 05/17/2005 | US6893856 Generating preferential compounds in sample; obtain sample, perform solid phase extraction, elute, recover compounds |
| 05/17/2005 | US6893843 Nucleic acids |
| 05/17/2005 | US6893841 Nucleotide sequences coding polypeptide for use in tool in treatment of defects in protein transport |
| 05/17/2005 | US6893838 DADD, death activator death domain protein |
| 05/17/2005 | US6893829 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 05/17/2005 | US6893818 Gene upregulated in cancers of the prostate |